Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-15
DOI
10.1038/s41598-017-09484-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Specific Mortality in Men Diagnosed with Prostate Cancer before Age 50 Years: A Nationwide Population Based Study
- (2017) Andreas Thorstenson et al. JOURNAL OF UROLOGY
- Impact of local treatment on overall survival of patients with metastatic prostate cancer: systematic review and meta-analysis
- (2017) Arie Carneiro et al. International Braz J Urol
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Upregulation of T-cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Monocytes/Macrophages Associates with Gastric Cancer Progression
- (2016) Zhenxin Wang et al. IMMUNOLOGICAL INVESTIGATIONS
- Favorable outcome of intraoperative radiotherapy to the primary site in patients with metastatic prostate cancer
- (2016) Toshihiro Kanda et al. International Journal of Clinical Oncology
- Predictors of poor response to secondary alternative antiandrogen therapy with flutamide in metastatic castration-resistant prostate cancer
- (2016) Masato Yasui et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival With Prostate Radiation in Addition to Androgen Deprivation Therapy for Men With Newly Diagnosed Metastatic Prostate Cancer
- (2016) Chad G. Rusthoven et al. JOURNAL OF CLINICAL ONCOLOGY
- TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway
- (2016) Baoen Shan et al. ONCOLOGY REPORTS
- Does Radiotherapy for the Primary Tumor Benefit Prostate Cancer Patients with Distant Metastasis at Initial Diagnosis?
- (2016) Yeona Cho et al. PLoS One
- Nomogram for overall survival of Japanese patients with bone-metastatic prostate cancer
- (2015) Yasuhide Miyoshi et al. BMC CANCER
- Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer
- (2015) M. Kato et al. CLINICAL CANCER RESEARCH
- Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)
- (2015) Nicholas David James et al. EUROPEAN UROLOGY
- Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma
- (2015) Liyun Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival
- (2015) Meng Yang et al. JOURNAL OF SURGICAL ONCOLOGY
- Advances in the Treatment of Metastatic Prostate Cancer
- (2015) Jong Chul Park et al. MAYO CLINIC PROCEEDINGS
- Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009
- (2015) Di Qi et al. PROSTATE
- Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma
- (2015) Chen Cai et al. WORLD JOURNAL OF UROLOGY
- Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
- (2015) Alejo Rodriguez-Vida et al. Drug Design Development and Therapy
- Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer
- (2015) Chiao-Wen Kang et al. Scientific Reports
- The Coordinated Actions of TIM-3 on Cancer and Myeloid Cells in the Regulation of Tumorigenicity and Clinical Prognosis in Clear Cell Renal Cell Carcinomas
- (2015) Y. Komohara et al. Cancer Immunology Research
- Constitutively Active AR-V7 Plays an Essential Role in the Development and Progression of Castration-Resistant Prostate Cancer
- (2015) Yuanyuan Qu et al. Scientific Reports
- Regulation of T cell responses by the receptor molecule Tim-3
- (2014) Jacob V. Gorman et al. IMMUNOLOGIC RESEARCH
- Prognostic impact of young age on stage IV prostate cancer treated with primary androgen deprivation therapy
- (2014) Tomokazu Kimura et al. INTERNATIONAL JOURNAL OF UROLOGY
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- The prognostic significance of Gleason scores in metastatic prostate cancer
- (2014) Chad G. Rusthoven et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Prognostic Value of T Cell Immunoglobulin Mucin-3 in Prostate Cancer
- (2013) Yong-Rui Piao et al. Asian Pacific Journal of Cancer Prevention
- An androgen receptor N-terminal domain antagonist for treating prostate cancer
- (2013) Jae-Kyung Myung et al. JOURNAL OF CLINICAL INVESTIGATION
- Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
- (2013) Jing Jiang et al. PLoS One
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
- (2011) Q. Zhou et al. BLOOD
- Anti-TIM3 Antibody Promotes T Cell IFN- -Mediated Antitumor Immunity and Suppresses Established Tumors
- (2011) S. F. Ngiow et al. CANCER RESEARCH
- Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
- (2011) Emma Hörnberg et al. PLoS One
- An update on androgen deprivation therapy for prostate cancer
- (2010) Nima Sharifi et al. ENDOCRINE-RELATED CANCER
- Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
- (2010) Shihua Sun et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels
- (2008) Bo Dai et al. ASIAN JOURNAL OF ANDROLOGY
- High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma
- (2008) Xiao-Dong Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started